Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Sci Rep ; 10(1): 13669, 2020 08 13.
Article in English | MEDLINE | ID: mdl-32792538

ABSTRACT

Wild mushroom foraging involves a high risk of unintentional consumption of poisonous mushrooms which is a serious health concern. This problem arises due to the close morphological resemblances of toxic mushrooms with edible ones. The genus Inocybe comprises both edible and poisonous species and it is therefore important to differentiate them. Knowledge about their chemical nature will unambiguously determine their edibility and aid in an effective treatment in case of poisonings. In the present study, the presence of volatile toxic metabolites was verified in Inocybe virosa by gas chromatography. Methyl palmitate, phenol, 3,5-bis (1,1-dimethyl ethyl) and phytol were the identified compounds with suspected toxicity. The presence of the toxin muscarine was confirmed by liquid chromatography. The in vitro study showed that there was negligible effect of the digestion process on muscarine content or its toxicity. Therefore, the role of muscarine in the toxicity of Inocybe virosa was studied using a bioassay wherein metameters such as hypersalivation, immobility, excessive defecation, heart rate and micturition were measured. Administration of muscarine resulted in an earlier onset of symptoms and the extract showed a slightly stronger muscarinic effect in comparison to an equivalent dose of muscarine estimated in it. Further, the biological fate of muscarine was studied by pharmacokinetics and gamma scintigraphy in New Zealand white rabbits. Significant amount of the toxin was rapidly and effectively concentrated in the thorax and head region. This study closely explains the early muscarinic response such as miosis and salivation in mice. By the end of 24 h, a relatively major proportion of muscarine administered was accumulated in the liver which stands as an explanation to the hepatotoxicity of Inocybe virosa. This is one of the rare studies that has attempted to understand the toxic potential of muscarine which has previously been explored extensively for its pharmaceutical applications.


Subject(s)
Agaricales/chemistry , Muscarine/toxicity , Thorax/chemistry , Toxins, Biological/isolation & purification , Animals , Brain Chemistry , Cell Line , Cell Survival/drug effects , Female , Gas Chromatography-Mass Spectrometry , Humans , Mice , Muscarine/administration & dosage , Muscarine/isolation & purification , Palmitates/isolation & purification , Phenol/isolation & purification , Phytol/isolation & purification , Rabbits , Toxins, Biological/chemistry
2.
J Comp Physiol B ; 186(1): 45-57, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26438517

ABSTRACT

The Drosophila melanogaster heart is a popular model in which to study cardiac physiology and development. Progress has been made in understanding the role of endogenous compounds in regulating cardiac function in this model. It is well characterized that common neurotransmitters act on many peripheral and non-neuronal tissues as they flow through the hemolymph of insects. Many of these neuromodulators, including acetylcholine (ACh), have been shown to act directly on the D. melanogaster larval heart. ACh is a primary neurotransmitter in the central nervous system (CNS) of vertebrates and at the neuromuscular junctions on skeletal and cardiac tissue. In insects, ACh is the primary excitatory neurotransmitter of sensory neurons and is also prominent in the CNS. A full understanding regarding the regulation of the Drosophila cardiac physiology by the cholinergic system remains poorly understood. Here we use semi-intact D. melanogaster larvae to study the pharmacological profile of cholinergic receptor subtypes, nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors (mAChRs), in modulating heart rate (HR). Cholinergic receptor agonists, nicotine and muscarine both increase HR, while nAChR agonist clothianidin exhibits no significant effect when exposed to an open preparation at concentrations as low as 100 nM. In addition, both nAChR and mAChR antagonists increase HR as well but also display capabilities of blocking agonist actions. These results provide evidence that both of these receptor subtypes display functional significance in regulating the larval heart's pacemaker activity.


Subject(s)
Drosophila melanogaster/physiology , Heart Rate/drug effects , Heart/physiology , Receptors, Cholinergic/metabolism , Acetylcholine/administration & dosage , Acetylcholine/pharmacology , Animals , Cholinergic Agonists/administration & dosage , Cholinergic Agonists/pharmacology , Cholinergic Antagonists/administration & dosage , Cholinergic Antagonists/pharmacology , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Heart/drug effects , Larva/drug effects , Larva/physiology , Muscarine/administration & dosage , Muscarine/pharmacology , Nicotine/administration & dosage , Nicotine/pharmacology , Receptors, Cholinergic/classification , Receptors, Cholinergic/genetics
3.
J Pharmacol Sci ; 117(4): 253-64, 2011.
Article in English | MEDLINE | ID: mdl-22095037

ABSTRACT

The muscarinic receptor is known to be involved in the acetylcholine (ACh)-induced secretion of catecholamines in the adrenal medullary (AM) cells of various mammals. The muscarinic receptor subtype involved and its physiological role, however, have not been elucidated yet. Thus, we investigated these issues in acutely isolated rat AM cells and perfused rat adrenal medulla. The RT-PCR analysis revealed the presence of M(2), M(3), M(4), and M(5) mRNAs. Immunocytochemistry with specific antibodies showed that M(5)-like immunoreactivities (IRs) were detected at half the cell membrane area, which was much larger than that with M(3)- or M(4)-like IRs. Muscarine produced inward currents in a dose-dependent manner. Pilocarpine, McN-A-343, and oxotremorine were less efficient than muscarine; and RS-86, which has no action on the M(5) receptor, produced no current. Electrical stimulation of nerve fibers produced a frequency-dependent increase in the Ca(2+) signal in perfused adrenal medullae. Muscarinic receptors were found to be involved in neuronal transmission in AM cells in the presence of a cholinesterase inhibitor, which suppresses ACh degradation. We concluded that the M(5) receptor is the major muscarinic receptor subtype in rat AM cells and may be involved in neuronal transmission under conditions where ACh spills over the synapse.


Subject(s)
Adrenal Medulla/metabolism , Muscarinic Agonists/pharmacology , Receptor, Muscarinic M5/metabolism , Receptors, Muscarinic/metabolism , Adrenal Medulla/cytology , Animals , Calcium Signaling , Cell Membrane/metabolism , Dose-Response Relationship, Drug , Electric Stimulation , HEK293 Cells , Humans , Muscarine/administration & dosage , Muscarine/pharmacology , Nerve Fibers/drug effects , Nerve Fibers/metabolism , Neurons/drug effects , Neurons/metabolism , Rats , Receptors, Muscarinic/drug effects , Reverse Transcriptase Polymerase Chain Reaction
4.
Pediatr Res ; 52(5): 756-62, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12409525

ABSTRACT

We investigated the effects of experimental colitis on the muscarinic signaling properties and contractile behavior of canine colonic circular smooth muscle. The hypotheses that inflammation 1) inhibits in vivo muscarinic receptor mediated contractions, and 2) alters receptor density or receptor-binding affinities were tested. Muscarine was infused close-intra-arterially in seven conscious dogs during normal and experimental colitis states. Colonic circular muscle contractions were recorded via surgically attached strain gauge transducers. Muscarine stimulated phasic contractions in a dose-dependent manner, whereas colitis was inhibited. The inhibitory concentration 50% dose of M(3) receptor inhibitor was several times lower than that of M(1), M(2), and M(4) inhibitors during normal and colitis. However, inflammation induced a significant leftward shift in the circular muscle inhibitory dose-response curve of M(2) inhibitor. Muscarinic receptor density and binding analyses in isolated circular muscle cells was done in normal and colitis states. Inflammation significantly decreased maximum binding from 4082 fmol/mg to 2708 fmol/mg, whereas affinity constant remained unaffected. The conclusions were that 1) spontaneous and muscarine-activated in vivo phasic contractile activity of colonic circular muscle cells is primarily mediated by M(3) receptors; 2) inflammation was associated with a shift in M(2) receptor potency, due chiefly to a decrease in receptor density; and 3) this inhibitory effect was seen in normal and inflamed states, suggesting the importance of M(2) receptor. These findings suggest that changes in muscarinic response during colitis may contribute to the abnormal motility seen with inflammatory bowel disease.


Subject(s)
Colitis/physiopathology , Muscle, Smooth/physiopathology , Receptors, Muscarinic/physiology , Animals , Cholinergic Agents/pharmacology , Colitis/chemically induced , Dogs , Female , Ganglionic Blockers/pharmacology , Hexamethonium/pharmacology , Infusions, Intra-Arterial , Male , Muscarine/administration & dosage , Muscarine/pharmacology , Muscarinic Antagonists/pharmacology , Muscle Contraction/drug effects , Peroxidase/analysis , Receptors, Muscarinic/drug effects , Tetrodotoxin/pharmacology
5.
Exp Brain Res ; 134(4): 490-6, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11081831

ABSTRACT

Behavioral experiments were conducted to examine the role of the cholinergic receptor-agonist muscarine or its antagonist homatropine on the mating behavior of sexually experienced male rats. Male copulatory behavior was recorded after intrathecally administered saline, muscarine (7.5 microg), or homatropine (25 microg). Changes in copulatory behavior were assessed by the following parameters: intromission latency, intromission frequency, intercopulatory interval, ejaculation latency, and postejaculatory interval. Intromission frequency, intercopulatory interval, and ejaculation latency were decreased significantly by muscarine. Intrathecal homatropine decreased the number of copulating animals (five out of 13). In the five animals that were able to ejaculate after homatropine, intromission latency, intercopulatory interval, and ejaculation latency increased significantly. The effects of both drugs on locomotion were also tested. Muscarine induced no significant changes in locomotion compared with saline. A significant increase in locomotion was found after homatropine treatment. These results suggest that acetylcholine, acting at spinal-cord muscarinic receptors, may be involved in ejaculation.


Subject(s)
Copulation/drug effects , Motor Activity/drug effects , Muscarine/pharmacology , Animals , Copulation/physiology , Ejaculation/drug effects , Ejaculation/physiology , Injections, Spinal , Male , Motor Activity/physiology , Muscarine/administration & dosage , Parasympatholytics/administration & dosage , Parasympatholytics/pharmacology , Rats , Rats, Wistar , Reaction Time , Spinal Cord/drug effects , Spinal Cord/physiology , Tropanes/administration & dosage , Tropanes/pharmacology
6.
Am J Physiol ; 277(2): G341-50, 1999 08.
Article in English | MEDLINE | ID: mdl-10444448

ABSTRACT

The aim of this study was to identify the subtypes of muscarinic receptors that mediate in vivo and in vitro canine ileal longitudinal muscle contractions and whether their role is modulated by inflammation. Previous studies have reported that circular muscle contractions are suppressed in ileal inflammation induced by mucosal exposure to ethanol and acetic acid. We found that inflammation had no significant effect on in vivo and in vitro spontaneous or muscarinic receptor-mediated contractions of the longitudinal muscle. The longitudinal muscle contractions were mediated primarily by the M(3) receptor subtype. However, the IC(50) of the M(2) receptor antagonist methoctramine was only 10 times greater than that of the M(3) receptor antagonist 4-DAMP in the longitudinal muscle, whereas it was 224 times greater in the circular muscle. M(2) receptor-coupled decrease of intracellular cAMP occurred in the longitudinal but not in the circular muscle from the normal ileum. Inflammation did not alter this coupling in the longitudinal muscle but established it in the circular muscle. In conclusion, M(2) receptors may play a greater role in the mediation of longitudinal muscle contractions than circular muscle contractions. Inflammation does not alter the contractility or the relative role of muscarinic receptor subtypes in longitudinal muscle cells. However, it modulates the M(2) receptor coupling to adenylate cyclase in the circular muscle.


Subject(s)
Ileitis/metabolism , Muscle, Smooth/metabolism , Adenylyl Cyclases/metabolism , Animals , Dogs , Gastrointestinal Motility/drug effects , Gastrointestinal Motility/physiology , Ileitis/pathology , Ileitis/physiopathology , In Vitro Techniques , Injections, Intra-Arterial , Muscarine/administration & dosage , Muscarine/pharmacology , Muscle, Smooth/drug effects , Muscle, Smooth/pathology , Muscle, Smooth/physiopathology , Protein Isoforms/metabolism , Protein Isoforms/physiology , Receptors, Muscarinic/metabolism , Receptors, Muscarinic/physiology
7.
Brain Res ; 805(1-2): 220-33, 1998 Sep 14.
Article in English | MEDLINE | ID: mdl-9733970

ABSTRACT

Cholinergic mechanisms in the septohippocampal pathway contribute to several cognitive functions and impaired cholinergic transmission in this pathway may be related to the memory loss and dementia that accompanies normal aging and Alzheimer's disease and behavioral studies suggest that muscarinic mechanisms in the medial septum/diagonal band of Broca (MSDB) may contribute to these functions. The goal of the present study was to begin a characterization of the physiological and pharmacological effects of muscarine on antidromically identified septohippocampal neurons (SHNs). Muscarinic agonists produced a concentration-dependent excitation in >90% of SHNs tested using extracellular recordings in an in vitro rat brain slice preparation. The SHNs excited by muscarine had a broad range of conduction velocities (0.2 to 3.7 m/s; mean: 1.6+/-0.06 m/s; n=110), suggesting involvement of neurons with both slow (possibly cholinergic) and fast (possibly GABAergic) conducting fibers. The muscarine-induced excitations in SHNs were found not to be mediated via M1, M2 or M4 receptors, as they were not blocked by the M1-selective antagonists, pirenzepine or telenzepine or by the M2/M4-selective antagonist, methoctramine. In contrast, the M3-selective antagonist, 4-DAMP-mustard, blocked muscarinic excitations in a majority of SHNs, indicating the presence of M3 as well as non-M3-type responses. McN-A-343, an M1 and M5-selective agonist, excited 33% of neurons tested, confirming involvement of non-M3 receptors (possibly M5) and M3 receptors. Since the cholinergic and GABAergic MSDB neurons together innervate almost every type of hippocampal neuron, the effects of muscarine on SHNs would also have a profound effect on hippocampal circuitry.


Subject(s)
Hippocampus/drug effects , Muscarine/pharmacology , Neurons/drug effects , Neurons/physiology , Receptors, Muscarinic/physiology , Septum Pellucidum/drug effects , Animals , Drug Administration Schedule , Electrophysiology , Frontal Lobe/cytology , Frontal Lobe/drug effects , Hippocampus/cytology , In Vitro Techniques , Male , Muscarine/administration & dosage , Muscarine/agonists , Rats , Rats, Sprague-Dawley , Septum Pellucidum/cytology
8.
Anesth Analg ; 82(5): 982-7, 1996 May.
Article in English | MEDLINE | ID: mdl-8610910

ABSTRACT

Our overall goal was to investigate the mechanism by which fentanyl attenuates acetylcholine-induced contraction in porcine coronary artery. We tested the hypothesis that fentanyl attenuates muscarinic coronary contraction via sigma receptor activation. Left coronary artery vascular rings were isolated from porcine hearts and were suspended in organ chambers for isometric tension recording. In untreated coronary vascular rings, acetylcholine administration resulted in dose-dependent contraction. Fentanyl attenuated acetylcholine-induced contraction. The sigma ligands--(+)-pentazocine, (+)-cyclazocine, haloperidol, and 1,3-di-o-tolylguanidine--also inhibited acetylcholine-induced contraction. In contrast, the selective sigma ligand, (+)-3-(3-hydroxyphenyl)-N-(1-propyl) piperidine failed to have an inhibitory effect on acetylcholine-induced contraction. Moreover, metaphit (1-[1(3-isothiocyanatophenyl)cyclohexyl]piperidine), which causes irreversible acylation of sigma receptors, only inhibited acetylcholine-induced contraction when it was present in the organ chamber. We also assessed the effects of inhibiting various points in the signal transduction pathway distal to naloxone-sensitive opioid receptor activation on acetylcholine-induced contraction. Selective (glybenclamide) and nonselective (tetraethylammonium) K(+)-channel inhibition, guanosine triphosphate-binding protein inactivation (pertussis toxin), and Type 1 and Type 2 dopamine receptor inhibition all failed to alter the attenuating effect of fentanyl on acetylcholine-induced contraction. Thus, neither sigma or opioid receptor activation is a prerequisite for fentanyl-induced inhibition of muscarinic coronary contraction.


Subject(s)
Anesthetics, Intravenous/pharmacology , Coronary Vessels/drug effects , Fentanyl/pharmacology , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Narcotics/pharmacology , Receptors, sigma/physiology , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Acetylcholine/administration & dosage , Acetylcholine/pharmacology , Anesthetics, Intravenous/administration & dosage , Animals , Cyclazocine/pharmacology , Dopamine Agonists/pharmacology , Dopamine Antagonists/pharmacology , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/pharmacology , Fentanyl/administration & dosage , Guanidines/pharmacology , Haloperidol/pharmacology , Muscarine/administration & dosage , Muscarinic Agonists/administration & dosage , Narcotic Antagonists/pharmacology , Narcotics/administration & dosage , Pentazocine/pharmacology , Phencyclidine/analogs & derivatives , Phencyclidine/pharmacology , Piperidines/pharmacology , Potassium Channel Blockers , Receptors, Dopamine/drug effects , Receptors, sigma/drug effects , Signal Transduction/drug effects , Swine , Vasoconstrictor Agents/administration & dosage , Vasodilator Agents/pharmacology
9.
J Pharmacol Exp Ther ; 269(2): 699-708, 1994 May.
Article in English | MEDLINE | ID: mdl-7514222

ABSTRACT

The present study was designed to characterize the antinociception produced by the administration of a muscarinic agonist, (+)-cis-methyldioxolane, into the rostral ventral medulla (RVM) of male Sprague-Dawley rats. Seven days after the implantation of 25-gauge stainless-steel guide cannulae, animals were injected with graded doses of (+)-cis-methyldioxolane, and antinociception was assessed by using the 52 degrees C hot-plate and tail-flick tests in a single-blind design. (+)-cis-Methyldioxolane produced dose-related hot-plate and tail-flick antinociception for 30 to 45 min peaking 5 to 10 min after RVM injection. The ED50 values of (+)-cis-methyldioxolane in the hot-plate and tail-flick tests were 2.4 and 1.7 nmol, respectively. Five-minute preinjections with 0.35 nmol of the muscarinic M1 receptor blocker pirenzepine competitively antagonized the antinociception produced by (+)-cis-methyldioxolane. The antinociception produced by RVM injections of the muscarinic M2 receptor blocker methoctramine was additive to the antinociceptive effects of (+)-cis-methyldioxolane when the two antinociceptive effects of (+)-cis-methyldioxolane when the two agents were combined. Twenty four-hour pretreatment of the RVM with the irreversible muscarinic receptor antagonist 4-diphenylacetoxy-N-[2-chloroethyl]-piperidine mustard blocked the antinociceptive effects of (+)-cis-methyldioxolane completely. Administration of 6 nmol of the nitric oxide synthase inhibitor L-NG-nitroarginine into the RVM competitively antagonized the antinociception produced by (+)-cis-methyldioxolane and (+)-muscarine in the hot-plate and tail-flick tests. Pretreatment with 100 nmol of L-arginine, but not D-arginine, significantly reversed the inhibitory effects of L-NG-nitroarginine on (+)-cis-methyldioxolane-produced antinociception. Pretreatment with 100 nmol of the guanylyl cyclase inhibitor methylene blue into the RVM profoundly antagonized the antinociception produced by (+)-cis-methyldioxolane. Neither buffer L-NG-nitroarginine, L-arginine-D-arginine or methylene blue altered hot-plate or tail-flick nociception when injected alone into the RVM. In contrast, either dibutyryl cyclic GMP or 8-bromo cyclic GMP, membrane-permeable cyclic GMP analogs, produced hot-plate and tail-flick antinociception when injected alone into the RVM. These data are consistent with the hypothesis that the antinociception produced by muscarinic stimulation of the RVM is mediated by an L-arginine/nitric oxide/cyclic GMP cascade.


Subject(s)
Analgesics/pharmacology , Dioxolanes/pharmacology , Medulla Oblongata/drug effects , Nitric Oxide/physiology , Parasympathomimetics/pharmacology , Amino Acid Oxidoreductases/antagonists & inhibitors , Animals , Cyclic GMP/analogs & derivatives , Cyclic GMP/pharmacology , Dibutyryl Cyclic GMP/pharmacology , Dioxolanes/administration & dosage , Drug Synergism , Guanylate Cyclase/antagonists & inhibitors , Male , Microinjections , Muscarine/administration & dosage , Muscarine/pharmacology , Nitric Oxide Synthase , Rats , Rats, Sprague-Dawley
10.
Brain Res ; 554(1-2): 329-32, 1991 Jul 19.
Article in English | MEDLINE | ID: mdl-1933315

ABSTRACT

3,4-dihydroxyphenylacetic acid (DOPAC) was measured by differential pulse voltammetry in the neostriatum of anesthetized rats. DL-Muscarine (2.9 nmol) applied into the substantia nigra pars compacta, increased DOPAC concentration in the ipsilateral neostriatum. This effect was blocked by pirenzepine (2.8 nmol), and potentiated by AF-DX 116 (2.8 nmol). These results indicate the existence of two types of muscarinic receptors on dopaminergic neurons, whose activation produces opposing effects on dopamine metabolism in neostriatum.


Subject(s)
3,4-Dihydroxyphenylacetic Acid/metabolism , Corpus Striatum/metabolism , Muscarine/pharmacology , Pirenzepine/pharmacology , Receptors, Muscarinic/physiology , Substantia Nigra/physiology , Animals , Corpus Striatum/drug effects , Electrochemistry/methods , Functional Laterality , Male , Muscarine/administration & dosage , Parasympatholytics/pharmacology , Pirenzepine/analogs & derivatives , Rats , Rats, Inbred Strains , Receptors, Muscarinic/drug effects , Stereotaxic Techniques , Substantia Nigra/drug effects
11.
Anat Anz ; 173(4): 199-208, 1991.
Article in English | MEDLINE | ID: mdl-1803944

ABSTRACT

The ultrastructural effects of drugs enhancing, by different mechanisms, cholinergic transmission in the crop-sac (the target for prolactin secretion in birds) and the anterior pituitary lactotrophs, were studied in pigeons (Columba livia). The systemic or intraventricular administration of physostigmine, carbachol and muscarine produced maximal crop-sac stimulation with milk-like secretion, as demonstrated by the observation of ultrastructural changes in the lactiferous areas through scanning and transmission electron microscopy of the crop-sac mucosa. A marked activation was also observed in anterior pituitary lactotrophs. Crop-sac and anterior pituitary lactotrophs stimulatory effects were prevented by an atropine pretreatment, but not by mecamylamine and pempidine pretreatments. The present results suggest that muscarinic receptors at the hypothalamic and/or anterior pituitary level are involved in avian species in the control of prolactin secretion.


Subject(s)
Columbidae/metabolism , Crop, Avian/drug effects , Parasympathomimetics/pharmacology , Pituitary Gland, Anterior/drug effects , Prolactin/metabolism , Animals , Atropine/administration & dosage , Atropine/pharmacology , Carbachol/administration & dosage , Carbachol/pharmacology , Columbidae/anatomy & histology , Crop, Avian/metabolism , Crop, Avian/ultrastructure , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/ultrastructure , Female , Golgi Apparatus/drug effects , Golgi Apparatus/ultrastructure , Infusions, Parenteral/veterinary , Injections, Intraventricular/veterinary , Mecamylamine/administration & dosage , Mecamylamine/pharmacology , Microscopy, Electron , Microscopy, Electron, Scanning , Mucous Membrane/drug effects , Mucous Membrane/metabolism , Mucous Membrane/ultrastructure , Muscarine/administration & dosage , Muscarine/pharmacology , Pempidine/administration & dosage , Pempidine/pharmacology , Physostigmine/administration & dosage , Physostigmine/pharmacology , Pituitary Gland, Anterior/metabolism , Pituitary Gland, Anterior/ultrastructure
13.
Eur Surg Res ; 11(1): 27-38, 1979.
Article in English | MEDLINE | ID: mdl-477695

ABSTRACT

Intraarterially administered muscarine induced predictable and reproducible experimental acute pancreatitis with a simultaneous increase in amylase levels in blood. Muscarine also caused a transient rise followed by a lowering of blood glucose levels. The stimulated amylase secretion was dose-response related. The guinea pigs survived 2--2 1/2 h after muscarine administration. Atropine (3 and 5 mg/kg), an antimuscarinic agent, injected intraperitoneally 2 h prior to muscarine administration, (a) inhibited muscarine-induced amylase secretion, and (b) marginally increased the survival time of guinea pigs, but could not sustain the animals for further experimentation. The high death rate of experimental animals prevented the use of this method as a model for investigation of experimental acute pancreatitis.


Subject(s)
Amylases/metabolism , Atropine/pharmacology , Furans/pharmacology , Muscarine/pharmacology , Pancreas/metabolism , Pancreatic Juice/metabolism , Pancreatitis/physiopathology , Acute Disease , Amylases/blood , Animals , Atropine/administration & dosage , Blood Glucose/analysis , Dose-Response Relationship, Drug , Female , Furans/administration & dosage , Guinea Pigs , Injections, Intra-Arterial , Injections, Intraperitoneal , Male , Muscarine/administration & dosage , Muscarine/antagonists & inhibitors , Pancreatitis/chemically induced , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...